文献速递关节外科

氨甲环酸时代,初次全关节置换术前血型筛查是否已过时?

In the Era of Tranexamic Acid, are Type and Screens for Primary Total Joint Arthroplasty Obsolete?
PubMed 文献 · J Arthroplasty · 2020-04-25

本研究回顾性分析1255例 unilateral primary TKA 或 THA 患者,评估取消术前血型筛查(T&S)的安全性。结果仅1.1%患者因术后失血性贫血需输血,无术中输血,取消T&S可能安全且经济。

要点

  • 初次全关节置换术后输血率仅1.1%,且均为术后失血性贫血。
  • 无患者需术中输血,取消术前T&S未增加紧急输血风险。
  • 单次T&S成本191.27美元,取消可节约费用。

核心结论

  • 在初次全膝关节或全髋关节置换患者中,取消术前血型筛查(T&S)似乎是安全且经济有效的做法。

研究设计与样本

  • 前瞻性收集数据回顾性分析,纳入1255例接受单侧初次全膝关节置换(TKA)或全髋关节置换(THA)的患者,识别术后30天内输血者。

主要发现

  • 共1255例患者,TKA 682例(54%),THA 573例(46%)。
  • 术前平均血红蛋白11.5 g/dL,术后第1天平均血红蛋白下降3.6 g/dL。
  • 输血患者中13例(93%)为THA,平均估计失血量378.6 mL。
  • 无患者需术中输血。

关键数值与推荐

  • 单次血型筛查(T&S)总成本为191.27美元。

临床怎么用

  • 对于接受初次单侧TKA或THA的患者,可考虑从标准术前医嘱中取消血型筛查,以节约成本且不增加紧急输血风险。

局限性

  • 本研究为回顾性分析,基于前瞻性收集的数据,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in technique and perioperative blood management have improved transfusion rates following unilateral primary total joint arthroplasty and led some centers to change their preoperative blood ordering protocols. The purpose of this study is to determine whether deleting type and screens (T&S) from preoperative order sets was safe for patients undergoing primary total knee (TKA) and total hip arthroplasty (THA) and to identify patients who required allogenic blood transfusion. METHODS: Prospectively collected data were reviewed to identify any patient with a hemoglobin (Hgb) drawn within 30 days of surgery who received a transfusion following a unilateral primary TKA or THA. RESULTS: A total of 1255 patients met inclusion criteria. Of the total, 682 (54%) were TKAs and 573 (46%) were THAs. The mean preoperative Hgb was 11.5 g/dL with an average delta Hgb of 3.6 g/dL on postoperative day 1. No patient required an intraoperative transfusion. Fourteen patients (mean age and body mass index, 67.9 and 29.0) required a transfusion (1.1%) for postoperative blood loss anemia. Of those transfused, 13 (93%) of the patients underwent THA with the mean estimated blood loss of 378.6 mL. The total cost for a patient obtaining a T&S is $191.27. CONCLUSION: In our series, the risk of blood transfusion was rare (1.1%) and occurred only secondary to postoperative blood loss anemia. There were no cases of intraoperative complication requiring urgent or emergent blood transfusion. Removing T&S from standard order sets for patients undergoing primary TKA or THA appears to be a safe and cost-effective practice.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Vestermark GL, Rowe TM, Martin JR, et al. In the Era of Tranexamic Acid, are Type and Screens for Primary Total Joint Arthroplasty Obsolete? J Arthroplasty. 2020. PMID: 32451280. doi:10.1016/j.arth.2020.04.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。